Back to School: How biopharma can reboot drug development. Access exclusive analysis here

SMART Anti-CD3 antibody: Phase II trial upate

The antibody is in ongoing Phase I/II studies to treat psoriasis

Read the full 117 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE